THE INTERNATIONAL PROGNOSTIC INDEX IS ASSOCIATED WITH OUTCOMES IN DIFFUSE LARGE B CELL LYMPHOMA AFTER CAR T CELL THERAPY

CD19-targeted chimeric antigen receptor T cells (CAR T cells) have shown excellent activity against relapsed and refractory (R/R) diffuse large B-cell lymphoma (DLBCL). CAR T cell therapy is associated with early toxicities, including cytokine release syndrome and neurotoxicity. The incidence and se...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Transplant Cell Ther
Main Authors: Garcia-Recio, Marta, Wudhikarn, Kitsada, Pennisi, Martina, Alonso-Trillo, Rosalia, Flynn, Jessica, Shouval, Roni, Afuye, Aishat O., Silverberg, Mari Lynne, Batlevi, Connie W, Parastoo, Dahi, Devlin, Sean, Giralt, Sergio, Halton, Elizabeth, Ruiz, Josel, Maloy, Molly, Mead, Elena, Palomba, Lia, Santomasso, Bianca, Sauter, Craig S, Scordo, Michael, Gunjan, Shah, Perales, Miguel-Angel
Formato: Artigo
Idioma:Inglês
Publicado: 2020
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8010220/
https://ncbi.nlm.nih.gov/pubmed/33781518
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jtct.2020.10.022
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares